Govt’s expert panel approves AstraZeneca/Oxford Covid-19 vaccine for emergency use

Updated on Jan 01, 2021 06:25 PM IST

The report of approval comes after British regulators on Wednesday granted authorisation to AstraZeneca’s vaccine to provide immunity against the coronavirus disease (Covid-19).

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration.(File Photo / REUTERS)
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration.(File Photo / REUTERS)
New Delhi | ByReuters | Posted by Kunal Gaurav

India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.

The approval paves the way for its rollout in the world’s second worst affected country.

A representative of India’s Central Drugs Standard Control Organization (CDSCO), whose experts are meeting for the second time this week and also considering two other vaccines, declined to comment.

Britain and Argentina have already authorised the vaccine for urgent public use.

India wants to start administering the shots soon.

It is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.

At more than 10 million, India has reported the second highest number of coronavirus cases after the United States, though its rate of infection has come down significantly from a mid-September peak.

Get Latest India Newsalong with Latest Newsand Top Headlinesfrom India and around the world.
SHARE THIS ARTICLE ON
SHARE
Story Saved
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Sunday, December 04, 2022
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals